NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced new findings demonstrating positive biochemical outcomes related to more...

Genomic Health, Inc. (Nasdaq: GHDX) today announced the presentation of eight studies that provide additional evidence of the value of Oncotype DX® tests in predicting clinically meaningful...

ASCO 2017 -- Thermo Fisher Scientific, the world leader in service science, today announced the expansion of two next-generation sequencing (NGS) assays that align with the most recent data...

Highpower International, Inc. (NASDAQ: HPJ), a developer, manufacturer, and marketer of lithium ion and nickel-metal hydride (Ni-MH) rechargeable batteries, battery management systems, and a...

Novartis announced today updated findings from the Phase III MONALEESA-2 study that reinforce the efficacy and safety of Kisqali® (ribociclib) plus letrozole in postmenopausal women with hormone...